View in EDS

2579P Development of a patient-reported outcome measure for individuals at risk for hereditary cancer: Phase I - IIIa of the EORTC QLQ-HCR30.

Saved in:
Bibliographic Details
Title: 2579P Development of a patient-reported outcome measure for individuals at risk for hereditary cancer: Phase I - IIIa of the EORTC QLQ-HCR30.
Authors: Engele, V.I.1 (AUTHOR), Vasiliou, V.2 (AUTHOR), Wheelwright, S.3 (AUTHOR), Sztankay, M.1 (AUTHOR), Puglisi, C.4 (AUTHOR), Pogoda, K.5 (AUTHOR), van Leeuwaarde, R.6 (AUTHOR), Bleiker, E.7 (AUTHOR), Abdel-Razeq, H.8 (AUTHOR), Fox, L.9 (AUTHOR), Lanceley, A.10 (AUTHOR), Dabakuyo-Yonli, S.11 (AUTHOR), Bjelic-Radisic, V.12 (AUTHOR), Nordin, A.13 (AUTHOR), Ioannidis, G.N.14 (AUTHOR), Kulís, D.15 (AUTHOR), Brédart, A.16 (AUTHOR), Arraras, J.I.17 (AUTHOR), Holzner, B.1 (AUTHOR), Oberguggenberger, A.S.1 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1384-S1385. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.3194